Antihyperglycemic effect of fraxetin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats

Biochimie

Volumn 95, Issue 10, 2013, Pages 1848-1854

  Murali, Raju ^a   Srinivasan, Subramani ^a   Ashokkumar, Natarajan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Diabetes mellitus; Fraxetin; Glucose; Streptozotocin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; FRAXETIN; FRUCTOSE BISPHOSPHATASE; GLUCOKINASE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN A1C; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CARBOHYDRATE METABOLISM; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCOGEN LIVER LEVEL; INSULIN BLOOD LEVEL; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

RATTUS; RATTUS NORVEGICUS;

DIABETES MELLITUS; FRAXETIN; GLUCOSE; STREPTOZOTOCIN;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; BODY WEIGHT; CARBOHYDRATE METABOLISM; COUMARINS; DIABETES MELLITUS, EXPERIMENTAL; DRUG ADMINISTRATION SCHEDULE; FRUCTOSE-BISPHOSPHATASE; GLUCOKINASE; GLUCOSE-6-PHOSPHATASE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLYCOGEN; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; INSULIN; LIVER; MALE; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 84883211783     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.06.013     Document Type: Article

References (45)

1. A. Aziz, and S. Wheat croft Insulin resistance in type 2 diabetes and obesity: implications for endothelial function Expert Rev. Cardiovasc. Ther. 9 2011 403 407
2. K. Ananda Prabu, C.T. Kumarappan, S. Christudas, and V.K. Kalaichelvan Effect of Biophytum sensitivum on streptozotocin and nicotinamide-induced diabetic rats Asian Pac. J. Trop. Biomed. 5 2012 31 35
3. D.R. Whiting, L. Guariguanta, C. Weil, and J.E. Shaw Diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 Diabetes Res. Clin. Pract. 94 2011 311 321
4. S. Tharkar, A. Devarajan, S. Kumpatla, and V. Viswanathan The socioeconomics of diabetes from a developing country: a population based cost of illness study Diabetes Res. Clin. Pract. 89 2010 334 340
5. M.A. McAnuff, F.O. Omoruyi, E.Y. Morrison, and H.N. Asemota Changes in some liver enzymes in streptozotocin-induced diabetic rats fed sapogenin extract from bitter yam (Dioscorea polygonoides) or commercial diosgenin West Indian Med. J. 54 2005 97
6. H.L. Cheng, H.K. Huang, and C.I. Chang A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP activated protein kinase J. Agric. Food Chem. 56 2008 6835 6843
7. V.P. Veerapur, K.R. Prabhakar, and B.S. Thippeswamy Antidiabetic effect of Dodonaea viscosa (L). Lacq. aerial parts in high fructose-fed insulin resistant rats: a mechanism based study Indian J. Exp. Biol. 48 2010 800 810
8. C. Bucolo, K.W. Ward, E. Mazzon, S. Cuzzocrea, and F. Drago Protective effects of a coumarin derivative in diabetic rats Invest. Ophthalmol. Vis. Sci. 50 2009 3846 3852
9. C. Bucolo, G.M. Leggio, F. Drago, and S. Salomone Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats Biochem. Pharmacol. 84 2012 88 92
10. B. Fernandez-Puntero, I. Barroso, and I. Iglesias Antioxidant activity of fraxetin: in vivo and ex vivo parameters in normal situation versus induced stress Biol. Pharm. Bull. 24 2001 777 784
11. J.R. Hoult, and M. Paya Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential Gen. Pharmacol. 27 1996 713 722
12. F.H. Dexeus, C.J. Logothetis, A. Sella, K. Fitz, R. Amato, J.M. Reuben, and N. Dozier Phase II study of coumarin and cimitidine in patients with metastatic renal cell carcinoma J. Clin. Oncol. 8 1990 325 329
13. M.F. Molina-Jimenez, M.I. Sanchez-Reus, and D. Andres Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells Brain Res. 1009 2004 9 16
14. C.R. Wu, M.Y. Huang, Y.T. Lin, H.Y. Ju, and H. Ching Antioxidant properties of Cortex Fraxini and its simple coumarins Food Chem. 104 2007 1464 1471
15. P. Kalaiarasi, and K.V. Pugalendi Antihyperglycemic effect of 18β-glycyrrhetinic acid, a glycone of glycyrrhizin, on streptozotocin- diabetic rats Eur. J. Pharmacol. 606 2009 269 273
16. D. Prabakaran, and N. Ashokkumar Antihyperglycemic effect of esculetin modulated carbohydrate metabolic enzymes activities in streptozotocin induced diabetic rats J. Funct. Foods 4 2012 776 783
17. P. Trinder Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor Ann. Clin. Biochem. 6 1969 24
18. E. Bisse, and E.C. Abragam New less temperature sensitive, microchromato graphic method for the separation and quantitation of glycosylated haemoglobin using a non cyanide buffer system J. Chromatogr. 344 1999 81 91
19. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
20. N. Brandstrup, J.E. Kirk, and C. Bruni The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages J. Gerontol. 12 1957 166 171
21. H.A. Ells, and H.N. Kirkman A colorimetric method for assay of erythrocytic glucose-6-phosphate dehydrogenase Proc. Soc. Exp. Biol. Med. 106 1961 607 609
22. H. Koide, and T. Oda Pathological occurrence of glucose-6-phosphatase in serum in liver diseases Clin. Chim. Acta 4 1959 554 561
23. C.H. Fiske, and J. Subbarow The colorimetric determination of phosphorous J. Biol. Chem. 66 1925 375 400
24. J.M. Gancedo, and C. Gancedo Fructose-1,6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non fermenting yeasts Arch. Mikrobiol. 76 1971 132 138
25. K.C. Ong, and H.E. Khoo Effects of myricetin on glycemia and glycogen metabolism in diabetic rats Life Sci. 67 2000 1695 1705
26. M. Zhang, X.Y. Lv, J. Li, Z.G. Xu, and L. Chen The characterization of high fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model Exp. Diabetes Res. 2008 2008 704045
27. B.D. Duncan Multiple ranges tests for correlated and heteroscedastic means Biometrics 13 1957 359 364
28. N. Burns, and B. Gold The effect of 3-methyladenine DNA glycosylase-mediated DNA repair on the induction of toxicity and diabetes by the beta-cell toxicant streptozotocin Toxicol. Sci. 95 2007 391 400
29. M. Wei, L. Ong, M.T. Smith, F.B. Ross, K. Schmid, A.J. Hoey, D. Burstow, and L. Brown The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes Heart Lung Circ. 12 2003 44 50
30. R. Balamurugan, V. Duraipandiyan, and S. Ignacimuthu Antidiabetic activity of γ -sitosterol isolated from Lippia nodi flora L. in streptozotocin induced diabetic rats Eur. J. Pharmacol. 667 2011 410 418
31. A. Ceriello Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54 2005 1 7
32. D. Edelman, M.K. Olsen, T.K. Dudley, A.C. Harris, and E.Z. Oddone Utility of hemoglobin A1c in predicting diabetes risk J. Gen. Intern. Med. 19 2004 1175 1180
33. N. Ashokkumar, and L. Pari Effect of N-benzoyl-d-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats Clin. Chim. Acta 351 2005 105 113
34. C. Meyer, H.J. Woerle, J.M. Dostou, S.L. Welle, and J.E. Gerich Abnormal renal, hepatic and muscle glucose metabolism following glucose ingestion in type 2 diabetes Am. J. Physiol. Endocrinol. Metab. 287 2004 1049 1056
35. L. Kang, A.A. Dunn-Meynell, V.H. Routh, L.D. Gaspers, Y. Nagata, T. Nishimura, J. Eiki, B.B. Zhang, and B.E. Levin Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing Diabetes 55 2006 412 420
36. F.M. Matschinsky, M.A. Magnuson, D. Zelent, T.L. Jetton, N. Doliba, Y. Han, R. Taub, and J. Grimsby The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy Diabetes 55 2006 1 12
37. A. Nakamura, Y. Terauchi, S. Ohyama, J. Kubota, H. Shimazaki, T. Nambu, I. Takamoto, N. Kubota, J. Eiki, N. Yoshioka, T. Kadowaki, and T. Koike Impact of small molecule glucokinase activator on glucose metabolism and beta-cell mass Endocrinology 150 2009 1147 1154
38. Y. Xu, B.W. Osborne, and R.C. Stanton Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex Am. J. Physiol. Renal. Physiol. 289 2005 1040 1047
39. S.A. Park, M.S. Choi, S.Y. Cho, J.S. Seo, U.J. Jung, M.J. Kim, M.K. Sung, Y.B. Park, and M.K. Lee Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice Life Sci. 79 2006 1207 1213
40. B. Ramesh, and K.V. Pugalendi Antihyperglycaemic effect of umbelliferone in STZ diabetic rats J. Med. Food 9 2006 562 566
41. E. Kurosaki, R. Nakano, K. Momose, A. Shimaya, T. Suzuki, M. Shibasaki, and H. Shikama Hypoglycemic agent YM440 suppresses hepatic glucose out put via gluconeogenesis by reducing glucose-6-phosphatase activity in obese Zucker rats Eur. J. Pharmacol. 468 2003 151 158
42. X. Xia, J. Yan, Y. Shen, K. Tang, J. Yin, Y. Zhang, D. Yang, H. Liang, J. Ye, and J. Weng Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis PLoS One 6 2011 16556
43. V. Barbora, S. Norbert, L.S. Robert, S. Aramesh, P.E. Richard, and B. Clifton High alanine amino transferase associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes Diabetes 51 2002 1889 1895
44. J.C. Ferrer, C. Favre, R.R. Gomis, J.M. Fernandez-Novell, M. García-Rocha, N. de la Iglesia, E. Cid, and J.J. Guinovart Control of glycogen deposition FEBS Lett. 546 2003 127 132
45. G. Saravananan, P. Ponmurugana, and G. Senthilkumar Modulatory effect of S-allylcysteine on glucose metabolism in streptozotocin induced diabetic rats J. Funct. Foods 1 2009 336 340